iShares iBonds Dec 2029 Term Corporate ETF (IBDU)
Live price chart, market sentiment, and community perspectives for iShares iBonds Dec 2029 Term Corporate ETF (AMEX: IBDU).
Live price chart, market sentiment, and community perspectives for iShares iBonds Dec 2029 Term Corporate ETF (AMEX: IBDU).
On our desk, we are looking at IBDU's structural appeal for retail clients seeking defined-maturity investment-grade exposure. With an expense ratio sitting right at the category floor of 0.10% and total assets hovering above $4 billion, the operational reliability from BlackRock is unquestionable. Sentiment across fixed-income forums leans toward accumulation for those who plan to hold through the December 2029 termination date, effectively bypassing reinvestment risk at the end of the decade.
From a risk management standpoint, we have to respect the historical drawdown profile. Even though Morningstar categorizes IBDU as Conservative with a risk score of 15, that 5-year maximum drawdown of -17.7%—exceeding both its category median and benchmark index during the 2022 rate shock—reminds us that longer-duration corporate books are sensitive to rapid policy shifts. However, as we approach late 2026, duration is mechanically shrinking every month, neutralizing that specific threat.
Watching the 50-day and 200-day moving averages on our terminals, IBDU is currently trading around $23.05 to $23.17, which puts it roughly 0.9% below its MA200 of $23.39. Combined with a weekly RSI hovering near 38.5, the fund exhibits modest oversold conditions and a short-term Barchart technical opinion score reflecting an 80% sell. Yet, for a target maturity vehicle, these technical dips are viewed less as structural decay and more as an opportunity to lock in a 30-day SEC yield of 4.59%.
When evaluating target maturity ETFs like IBDU for asset-liability matching protocols, the key operational benchmark is turnover—currently sitting at a minimal 4%. This low turnover, coupled with a tight bid-ask spread around 0.04%, makes execution clean for block orders. Analysts modeling the portfolio must account for the steady convergence toward par value as December 2029 nears, transforming the instrument from a traditional duration play into a near-cash glide path.
In our portfolio strategy meetings, the math on carry is doing the heavy lifting. The SEC yield of 4.59% paired with a YTM of 4.69% offers a clear nominal baseline, which translates to a real yield roughly 2.3% to 2.6% above the Fed's 2% target. Short interest has also plummeted by over 37% down to roughly 120,841 shares, representing a tiny 0.07% of the public float with a days-to-cover ratio of just 0.2. Bearish speculative positioning is essentially non-existent.
Explore plasma cleansing, somatic organ swaps, and BCI.